Anavex Life Sciences (AVXL)

NASDAQ

$1.34

$-0.02

(-1.47%)

Regular Market

Anavex Life Sciences (AVXL) Live Price Chart

Last updated: ⁦2026-10-21 17:36:40⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Anavex Life Sciences (AVXL) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $1.34, with a market capitalization of $115.87M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.14 to $9.50. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$115.87M
Open	$1.40
Day's High	$31.50
Day's Low	$1.14
Previous Close	$1.36
Volume	650.07K
Average Volume	1.04M
P/E Ratio	--
52-Week High	$9.50
52-Week Low	$1.14
Dividend Yield	--
Earnings Date	--

Anavex Life Sciences (AVXL) Stock Price Today

Anavex Life Sciences (AVXL) is currently trading at $1.34 as of 2026-10-21 17:20:12, down 1.84% ($0.03) from the previous close of $1.36

During today's regular trading session, AVXL has traded between $1.14 and $31.50, with a trading volume of 650.07K shares. The current price is near the lower end of today's range.

Anavex Life Sciences (AVXL) 7-Day Stock Price Change

Over the past seven days, Anavex Life Sciences (AVXL) moved from $1.51 to $1.34, representing a decline of 11.59% ($0.18).

The stock traded between $1.14 and $1.55 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.

The average daily volume was 1.49 million shares, down versus the previous seven-day period, indicating lower trading activity.

AVXL 52-Week Price Position

Position in Range: 2.3%

52W Low$1.14

52W High$9.50

AVXL is currently trading at $1.34, placing it 2.3% of the way from its 52-week low of $1.14 to its 52-week high of $9.50. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Anavex Life Sciences (AVXL)?

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

Anavex Life Sciences Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	34
Exchange	NASDAQ
Company Website	https://www.anavex.com

How to Buy Anavex Life Sciences (AVXL) Stock on MEXC

Eligible investors can buy real shares of Anavex Life Sciences (AVXL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for AVXL and Place Your Order

Open the RealStocks trading page and search for AVXL. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Anavex Life Sciences (AVXL) stock price today?

Anavex Life Sciences (AVXL) is currently trading at $ 1.34, down 1.84% ($0.03) from the previous close of $ 1.36. Intraday prices update in real time during regular trading hours.

2.Is AVXL stock going up or down today?

As of 2026-10-21 17:20:12, AVXL is trading at $ 1.34, down 1.84% ($0.03) from its previous close of $ 1.36. The stock has traded between $ 1.14 and $ 31.50 during today’s regular session. Past price movements do not guarantee future results.

3.What is AVXL pre-market price?

As of 2026-10-21 17:20:12, AVXL is trading at $ 1.39 in pre-market trading, up 1.84% ($0.02) from the previous close of $ 1.36. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is AVXL after-hours price?

As of 2026-10-21 17:20:12, AVXL is trading at $ 1.45 in after-hours trading, up 6.84% ($0.09) from the regular-session close of $ 1.36. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is AVXL stock trading now?

AVXL trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does AVXL sit relative to its 52-week high and low?

Over the past 52 weeks, AVXL has traded between a low of $ 1.14 and a high of $ 9.50. At $ 1.34, the stock is positioned 2.3% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Anavex Life Sciences in?

Anavex Life Sciences (AVXL) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Anavex Life Sciences's market capitalization and where is it listed?

Anavex Life Sciences is listed on the NASDAQ exchange with a market capitalization of $ 115.87M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is AVXL valued in terms of P/E ratio and EPS?

AVXL trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.14. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Anavex Life Sciences pay a dividend?

Anavex Life Sciences pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.